Removal of Transcatheter Septal Occlusion Device in a Patient with Ventricular Septal Defect

Authors

  • Otoniel Toledo Salinas Instituto Mexicano del Seguro Social
  • Jorge Medina Romero
  • Francisco Javier Reyes Álvarez
  • Pedro Gerardo Dávila Flores

Keywords:

cardiac septal defects, septal occluder device

Abstract

Introduction: Complications associated with the placement procedure of a septal occlusion device occur in less than 10% of cases. Embolization requires cardiac surgery, which increases the risk of mortality.

Objective: To report the case of a patient with ventricular septal defect and severe pulmonary hypertension who had the transcatheter septal occlusion device removed.

Case report: We report the case report of a 24-year-old woman with ventricular septal defect, heart failure (New York Heart Association) class IV and type 2 pulmonary hypertension. She was scheduled for placement of a septal occlusion device, however, the placement of the device failed and had a residual defect of 7 mm, so the placement was removed 48 hours later without complications.

Conclusions: Although transcatheter closure of the ventricular septal defect is a safe and effective alternative to surgery, it is not free of complications. In case of translocation of the septal occlusion device, it must be removed during the same procedure, since the risk of embolization is high and if it occurs, the risk of death increases.

Downloads

Download data is not yet available.

Author Biography

Otoniel Toledo Salinas, Instituto Mexicano del Seguro Social

Adscrito a la Unidad de Cuidados Intensivos del Hospital de Especialidades Centro Médico Nacional La Raza

Published

2023-12-14

How to Cite

1.
Toledo Salinas O, Medina Romero J, Reyes Álvarez FJ, Dávila Flores PG. Removal of Transcatheter Septal Occlusion Device in a Patient with Ventricular Septal Defect. Rev Cubana Med [Internet]. 2023 Dec. 14 [cited 2025 Dec. 24];62(4). Available from: https://revmedicina.sld.cu/index.php/med/article/view/3176